Explore our targeted, active ingredient-rich serums and acne-care formulations
Navigating clinical efficacy, active ingredient sourcing stabilization, and volume supply chain dynamics in global medical and cosmetic channels.
Global brands and clinical distributors now demand medical-grade solutions. Acne treatment must exhibit reliable mechanisms for sebum regulation, follicular hyperkeratinization prevention, and inflammation reduction. B2B buyers require documented biological pathways, such as the modulation of Cutibacterium acnes biofilms, supported by stability data.
Enterprise sourcing demands continuous volume stability, sterile processing controls, and minimal batch-to-batch variation. Standardized raw materials, cleanroom production lines, and traceable active pharmaceutical or advanced cosmetic ingredients are basic criteria for selection.
With rising user awareness of the skin barrier, modern acne therapy focuses on reducing trans-epidermal water loss (TEWL) during treatment. Formulating active acne creams containing soothing agents like Centella Asiatica, Madecassoside, and Glyceroglucoside is crucial to mitigate the side effects of traditional peeling agents.
Acne is a primary concern in both juvenile and adult demographics. Developing a robust, marketable, and highly effective acne product requires navigating a complex environment of dermatologist endorsement, chemical engineering, and regulatory validation.
The transition from harsh topical treatments to restorative, microbiome-friendly anti-acne formulations marks a paradigm shift in cosmetic dermatology. Successful brands do not simply target lesions; they address the cutaneous ecosystem as a whole. Our manufacturing services bridge this gap by delivering stable, bio-active rich creams and serums designed to treat acne while actively restoring the lipid barrier.
Maintained under accelerated environmental aging tests over 36 months.
Meets all European Economic Area safety, health, and environmental demands.
Highly controlled environments ensuring sterile production & filling processes.
Active product delivery to North America, Europe, Asia, and Oceania.
Analyzing active delivery mechanisms, bio-tech synthesis, and targeted cellular therapy.
Traditional creams relied purely on surface exfoliation. Modern formulas combine lipophilic beta-hydroxy acids with hydrophilic alpha/poly-hydroxy acids. This dual-action pathway guarantees pore unclogging at the follicular junction while accelerating epidermal cell turnover on the skin's surface, minimizing micro-comedone formation.
Future pipelines focus heavily on prebiotics, probiotics, and postbiotic lysates. By maintaining a diverse cutaneous microbiome, we limit the opportunistic colonization of pathogenic C. acnes phylotypes without broad-spectrum sterilization, which often results in severe skin sensitivity and barrier degradation.
Leveraging bioactive peptides (such as Blue Copper Peptides and SNAP-8) and PDRN (Polydeoxyribonucleotide) allows us to design products that stimulate dermal fibroblasts. This accelerates tissue regeneration, reduces the likelihood of atrophic acne scarring, and optimizes cellular defense systems.
Guangzhou NeoKis Beauty Co., Ltd. is a professional China facial serum manufacturer specializing in the research, development, and production of advanced skincare solutions for global beauty brands, retailers, distributors, and private label businesses. The company focuses on creating high-quality facial serum formulations designed to support hydration, skin brightening, anti-aging care, and overall skin health.
NeoKis Beauty offers a comprehensive range of skincare products, including Vitamin C serums, hydrating serums, anti-aging serums, hyaluronic acid serums, niacinamide serums, peptide serums, brightening serums, firming serums, soothing serums, and customized skincare formulations. Developed to meet diverse consumer preferences and skincare needs, the company's products are suitable for multiple market segments across North America, Europe, Asia, the Middle East, and emerging global markets.
Equipped with modern manufacturing facilities and advanced production technologies, NeoKis Beauty implements strict quality management procedures throughout every stage of production. From ingredient sourcing and formulation development to filling, packaging, and final inspection, each process is carefully monitored to ensure product consistency, safety, and performance.
The company's experienced R&D team continuously explores innovative skincare ingredients and formulation technologies to support changing beauty trends and market demands. In addition to standard product lines, NeoKis Beauty provides flexible OEM and ODM services, helping clients develop customized skincare products, exclusive formulations, private label collections, and brand-specific packaging solutions.
Serving beauty brands, e-commerce sellers, skincare startups, wholesalers, and international distributors, Guangzhou NeoKis Beauty Co., Ltd. is committed to delivering reliable manufacturing support, scalable production capacity, and customer-focused service. Through continuous innovation and quality-driven manufacturing, the company aims to be a trusted partner in the global skincare and facial serum industry.
Explore our state-of-the-art facilities designed for precise compound mixing, sterile filling, packaging, and high-performance quality control testing.
Exporting active acne treatments to highly regulated jurisdictions like the European Union requires stringent adherence to safety validation mechanisms. CE Certification under EU Regulation is a benchmark of consumer safety, verification of chemical composition stability, and manufacturing compliance.
Our formulations are accompanied by complete Product Information Files (PIFs), including safety assessments conducted by certified toxicologists. We ensure that every batch meets maximum allowable concentrations for regulated substances, offering a seamless path to market registration for our global B2B clients.
We supply more than just high-quality bulk formulas; we provide end-to-end regulatory support designed for the markets you target:
Understanding regional markets, active demand vectors, and supply chain logistics for B2B procurement partners.
High demand for rapid-action salicylic acid and benzoyl peroxide based formulas. Increasingly shifting towards "clinical-clean" profiles containing botanicals (Centella Asiatica, witch hazel) to reduce irritation markers.
Strict focus on safety, requiring rigorous toxicology profiles. High demand for CE-compliant anti-acne repair creams featuring retinoids, dicarboxylic acids (Mandelic/Azelaic), and barrier repair peptides.
Dominated by lightweight serums and hydro-suspensions. High market growth for gentle exfoliating agents (mandelic acid, gluconolactone) paired with hydration boosters like hyaluronic acid and PDRN.
Common technical, regulatory, and production queries resolved by our senior R&D and compliance engineers.
CE certification signifies that the formulation complies with the high safety, health, and environmental protection standards of the European Economic Area (EEA). For skincare products, this verification process involves rigorous safety assessments, toxicology reports, and production standard audits under ISO 22716, ensuring that the topical formulation is stable, non-toxic, and fit for global commercialization.
Our R&D team uses advanced carrier systems (like liposome encapsulation) to deliver peeling actives like salicylic acid or mandelic acid directly to the hair follicle, reducing irritation on the outer skin layer. We also blend these chemical exfoliants with healing bio-actives like Centella Asiatica, Glyceroglucoside, and Blue Copper Peptides. This combination reduces inflammation and supports barrier recovery during treatment.
Guangzhou NeoKis Beauty Co., Ltd. provides full-service OEM and ODM support. This includes customized formulation development in our advanced R&D lab, ingredient sourcing, manufacturing in a Class 100,000 cleanroom, airless or customized packaging sourcing, stability/regulatory testing, and assistance with global compliance filings (such as FDA, CE, and CPNP).
MOQs vary depending on the customization level, bottle design, and formula complexity. Generally, for standard private label solutions, MOQs start at 1,000 to 3,000 units. For fully customized chemical formulations and custom container designs, the MOQ starts at 5,000 to 10,000 units. Please contact our sales representatives directly for a tailored quote based on your specific requirements.
Complete your catalog with advanced serums, chemical exfoliators, and home-use beauty equipment
NeoKis Beauty
